Zobrazeno 1 - 10
of 138
pro vyhledávání: '"D, Mayeux"'
Publikováno v:
Pulmonary Circulation, Vol 13, Iss 1, Pp n/a-n/a (2023)
Abstract The considerable progress made in recent years in the diagnosis, risk stratification, and treatment of pulmonary hypertension was highlighted during the most recent edition of the Pulmonary Hypertension Association Scientific Sessions, which
Externí odkaz:
https://doaj.org/article/1c7ccd20fe63483796cf73388e063293
Autor:
Irene Z. Pan, Jessica R. Carey, Joshua A. Jacobs, John Dechand, Joshua J. Sessions, Teshia Sorensen, Brittany A. Penn, Jennalyn D. Mayeux, Nathan D. Hatton, John J. Ryan
Publikováno v:
Frontiers in Medicine, Vol 7 (2020)
Background: New oral prostacyclin therapies and prostacyclin agonists have become available for the treatment of pulmonary arterial hypertension (PAH). However, methods for transitioning between oral, inhaled, and parenteral formulations are not well
Externí odkaz:
https://doaj.org/article/50b9f343a69940369224e9edc58262c3
Autor:
Dominique Ingram, Ayedh K Alamri, Brittany A Penn, Jennalyn D Mayeux, Christy L Ma, Katharine R Clapham, Anu E Abraham, Dana Klanderud, Ben Sadeh, Emily M Beck, Nathan D Hatton, John J Ryan
Publikováno v:
Cureus. 14(11)
Background Since the initial description in the 1980s, our understanding of the diversity of pulmonary arterial hypertension (PAH) has continued to evolve. In this study, we report the characteristics of patients seen in an academic medical center fo
Autor:
John J. Ryan, Tara L. Jones, Irene Z. Pan, Emily Beck, Stephen H. McKellar, Nathan D. Hatton, John Dechand, Joshua A. Jacobs, Jennalyn D. Mayeux
Publikováno v:
Current Cardiovascular Risk Reports. 15
Autor:
Nathan D. Hatton, Jennalyn D. Mayeux, John J. Ryan, Stephen H. McKellar, Irene Z. Pan, Joshua A. Jacobs, Tara L. Jones, John Dechand, Emily Beck
Publikováno v:
Current Cardiovascular Risk Reports
Purpose of Review This review focuses on the therapeutic management and individualized approach to Group 1 pulmonary arterial hypertension (PAH), utilizing Food and Drug Administration-approved PAH-specific therapies and various interventional and su
Autor:
Nathan D. Hatton, Erin S. Michaelis, John J. Ryan, Jennalyn D. Mayeux, Doran Bostwick, Courtney L. Sheets
Publikováno v:
Advances in Pulmonary Hypertension. 16:103-111
Dyspnea is defined by the American Thoracic Society as a “subjective experience of breathing discomfort that consists of qualitatively distinct sensations that vary in intensity.”1 It is a common nonspecific symptom in patients presenting to both
Publikováno v:
Revue d'Épidémiologie et de Santé Publique. 67:S69
Publikováno v:
Revue d'Épidémiologie et de Santé Publique. 65:S3
Publikováno v:
Nephrology Dialysis Transplantation. 13:1776-1781
ies suggest that in these cases erythrocytosis may be caused by defective regulation of erythroid progenitor Background. Erythrocytosis is relatively common after renal transplantation and is associated with a higher proliferation, possibly due to pa
Publikováno v:
Nephrology Dialysis Transplantation. 11:1043-1047